Interview: Hemogenyx

This post was written by Zak Mir, a Technical Analyst, Events Host, Presenter, CEO Interviewer and established Market Commentator

The Hemogenyx breakthrough heralds the double whammy of the end of chemotherapy and the need for bone marrow transplants to treat blood diseases, as well as a new investment situation.

Dr. Vladislav Sandler is the founder and CEO of Hemogenyx and Adrian Beestan, Director at Hemogenyx Pharmaceuticals talk to host Zak Mir about the company’s mission.

 

[youtube https://www.youtube.com/watch?v=6kG7G_Hwo9U&w=560&h=315]
Zak Mir

Zak Mir

About Me

Zak Mir is a Technical Analyst, Events Host, Presenter, CEO Interviewer and established Market Commentator. Zak presents the daily Bulletin Board Heroes which can be seen here at Share Talk

Recent Posts

Zak Mir Twitter

RT @DavidLenigas: #Gold price forecasts I was sent this morning. ⁦@WishboneGoldplc⁩ ⁦@GreatlandGold⁩ ⁦@NQ_Minerals⁩ ⁦@Empiremetalsltd⁩... Read More

Jan 25 2021, 8:01 pm

RT @John_Mahtani: #RDGC - after the pullback this morning @ashpat01 and @John_Mahtani decided to top... Read More

Jan 25 2021, 7:22 pm

RT @EvertonRob1: I have a funny feeling we will be testing new high’s for #Dev... Read More

Jan 25 2021, 6:22 pm

Bulliten Board Heroes